Celldex Therapeutics
CLDX
#4967
Rank
A$2.13 B
Marketcap
$32.21
Share price
1.07%
Change (1 day)
-52.90%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -$3.60

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.80. In 2022 the company made an earnings per share (EPS) of -$3.78 a decrease over its 2021 EPS that were of -$2.59.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.60-4.72%
2022-$3.7845.73%
2021-$2.59-23.36%
2020-$3.39-41.05%
2019-$5.74-76.95%
2018-$24.9245.03%
2017-$17.18-42.54%
2016-$29.90-3.82%
2015-$31.09-0.76%
2014-$31.3329.41%
2013-$24.210%
2012-$24.21-9.73%
2011-$26.821312.5%
2010-$1.90-95.79%
2009-$45.06-49.64%
2008-$89.47-82.64%
2007-$515.48-44.98%
2006-$936.981270.83%
2005-$68.3533.33%
2004-$51.26-10%
2003-$56.96-16.67%
2002-$68.35-38.46%
2001-$111.07-4.88%
2000-$116.77-81.66%
1999-$636.52-87.2%
1998-$4,971206.39%
1997-$1,62213.02%
1996-$1,436

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$6.34 67.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.34-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-$19.11 403.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.39-689.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.94-177.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.54-245.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$0.90-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA